nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenoxicam—PTGS1—esophageal cancer	0.418	0.636	CbGaD
Tenoxicam—PTGS2—esophageal cancer	0.239	0.364	CbGaD
Tenoxicam—PTGS2—Cisplatin—esophageal cancer	0.0917	0.37	CbGbCtD
Tenoxicam—SLC22A8—Methotrexate—esophageal cancer	0.0633	0.255	CbGbCtD
Tenoxicam—CYP2C9—Capecitabine—esophageal cancer	0.0619	0.25	CbGbCtD
Tenoxicam—CYP2C9—Cisplatin—esophageal cancer	0.0312	0.126	CbGbCtD
Tenoxicam—Gastrointestinal ulcer—Methotrexate—esophageal cancer	0.00289	0.0686	CcSEcCtD
Tenoxicam—Gastrointestinal perforation—Capecitabine—esophageal cancer	0.0023	0.0546	CcSEcCtD
Tenoxicam—Lornoxicam—PTGS1—esophageal cancer	0.00171	0.291	CrCbGaD
Tenoxicam—Meloxicam—PTGS1—esophageal cancer	0.00108	0.185	CrCbGaD
Tenoxicam—Lornoxicam—PTGS2—esophageal cancer	0.000975	0.166	CrCbGaD
Tenoxicam—Piroxicam—PTGS1—esophageal cancer	0.000939	0.16	CrCbGaD
Tenoxicam—Haematemesis—Capecitabine—esophageal cancer	0.000865	0.0205	CcSEcCtD
Tenoxicam—Haematemesis—Methotrexate—esophageal cancer	0.000644	0.0153	CcSEcCtD
Tenoxicam—Meloxicam—PTGS2—esophageal cancer	0.000619	0.106	CrCbGaD
Tenoxicam—Gastrointestinal haemorrhage—Cisplatin—esophageal cancer	0.000592	0.014	CcSEcCtD
Tenoxicam—Melaena—Capecitabine—esophageal cancer	0.000587	0.0139	CcSEcCtD
Tenoxicam—Colitis—Capecitabine—esophageal cancer	0.000577	0.0137	CcSEcCtD
Tenoxicam—Piroxicam—PTGS2—esophageal cancer	0.000537	0.0916	CrCbGaD
Tenoxicam—Breast disorder—Cisplatin—esophageal cancer	0.000535	0.0127	CcSEcCtD
Tenoxicam—Sleep disorder—Capecitabine—esophageal cancer	0.000504	0.0119	CcSEcCtD
Tenoxicam—Abdominal discomfort—Cisplatin—esophageal cancer	0.000491	0.0116	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Cisplatin—esophageal cancer	0.00045	0.0107	CcSEcCtD
Tenoxicam—Myocardial infarction—Cisplatin—esophageal cancer	0.000447	0.0106	CcSEcCtD
Tenoxicam—Cardiac failure—Capecitabine—esophageal cancer	0.000447	0.0106	CcSEcCtD
Tenoxicam—Stomatitis—Cisplatin—esophageal cancer	0.000445	0.0105	CcSEcCtD
Tenoxicam—Melaena—Methotrexate—esophageal cancer	0.000437	0.0104	CcSEcCtD
Tenoxicam—Gastrointestinal haemorrhage—Capecitabine—esophageal cancer	0.000436	0.0103	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000431	0.0102	CcSEcCtD
Tenoxicam—Urinary tract disorder—Cisplatin—esophageal cancer	0.000404	0.00958	CcSEcCtD
Tenoxicam—Urethral disorder—Cisplatin—esophageal cancer	0.000401	0.00951	CcSEcCtD
Tenoxicam—Visual impairment—Cisplatin—esophageal cancer	0.000395	0.00935	CcSEcCtD
Tenoxicam—Breast disorder—Capecitabine—esophageal cancer	0.000394	0.00934	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000393	0.00931	CcSEcCtD
Tenoxicam—Gastritis—Capecitabine—esophageal cancer	0.000386	0.00915	CcSEcCtD
Tenoxicam—Eye disorder—Cisplatin—esophageal cancer	0.000383	0.00907	CcSEcCtD
Tenoxicam—Cardiac disorder—Cisplatin—esophageal cancer	0.00038	0.00901	CcSEcCtD
Tenoxicam—Asthma—Capecitabine—esophageal cancer	0.000377	0.00894	CcSEcCtD
Tenoxicam—Immune system disorder—Cisplatin—esophageal cancer	0.00037	0.00877	CcSEcCtD
Tenoxicam—Abdominal discomfort—Capecitabine—esophageal cancer	0.000362	0.00857	CcSEcCtD
Tenoxicam—Erythema—Cisplatin—esophageal cancer	0.000357	0.00845	CcSEcCtD
Tenoxicam—Malnutrition—Cisplatin—esophageal cancer	0.000357	0.00845	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Capecitabine—esophageal cancer	0.000344	0.00816	CcSEcCtD
Tenoxicam—Visual disturbance—Methotrexate—esophageal cancer	0.000343	0.00812	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.000333	0.0079	CcSEcCtD
Tenoxicam—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000332	0.00786	CcSEcCtD
Tenoxicam—Myocardial infarction—Capecitabine—esophageal cancer	0.00033	0.00781	CcSEcCtD
Tenoxicam—Anaemia—Cisplatin—esophageal cancer	0.00033	0.00781	CcSEcCtD
Tenoxicam—Stomatitis—Capecitabine—esophageal cancer	0.000328	0.00777	CcSEcCtD
Tenoxicam—Leukopenia—Cisplatin—esophageal cancer	0.000319	0.00756	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000318	0.00754	CcSEcCtD
Tenoxicam—Agranulocytosis—Capecitabine—esophageal cancer	0.000314	0.00744	CcSEcCtD
Tenoxicam—Hepatitis—Capecitabine—esophageal cancer	0.000302	0.00715	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000301	0.00714	CcSEcCtD
Tenoxicam—Urinary tract disorder—Capecitabine—esophageal cancer	0.000298	0.00706	CcSEcCtD
Tenoxicam—Urethral disorder—Capecitabine—esophageal cancer	0.000296	0.00701	CcSEcCtD
Tenoxicam—Breast disorder—Methotrexate—esophageal cancer	0.000294	0.00696	CcSEcCtD
Tenoxicam—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000293	0.00693	CcSEcCtD
Tenoxicam—Anaphylactic shock—Cisplatin—esophageal cancer	0.000291	0.00689	CcSEcCtD
Tenoxicam—Oedema—Cisplatin—esophageal cancer	0.000291	0.00689	CcSEcCtD
Tenoxicam—Visual impairment—Capecitabine—esophageal cancer	0.000291	0.00689	CcSEcCtD
Tenoxicam—Erythema multiforme—Capecitabine—esophageal cancer	0.000285	0.00676	CcSEcCtD
Tenoxicam—Nervous system disorder—Cisplatin—esophageal cancer	0.000285	0.00676	CcSEcCtD
Tenoxicam—Thrombocytopenia—Cisplatin—esophageal cancer	0.000285	0.00675	CcSEcCtD
Tenoxicam—Skin disorder—Cisplatin—esophageal cancer	0.000283	0.0067	CcSEcCtD
Tenoxicam—Eye disorder—Capecitabine—esophageal cancer	0.000282	0.00669	CcSEcCtD
Tenoxicam—Asthma—Methotrexate—esophageal cancer	0.000281	0.00665	CcSEcCtD
Tenoxicam—Cardiac disorder—Capecitabine—esophageal cancer	0.00028	0.00664	CcSEcCtD
Tenoxicam—Anorexia—Cisplatin—esophageal cancer	0.000277	0.00657	CcSEcCtD
Tenoxicam—Angiopathy—Capecitabine—esophageal cancer	0.000274	0.00649	CcSEcCtD
Tenoxicam—Immune system disorder—Capecitabine—esophageal cancer	0.000273	0.00646	CcSEcCtD
Tenoxicam—Abdominal discomfort—Methotrexate—esophageal cancer	0.000269	0.00638	CcSEcCtD
Tenoxicam—Mental disorder—Capecitabine—esophageal cancer	0.000265	0.00627	CcSEcCtD
Tenoxicam—Erythema—Capecitabine—esophageal cancer	0.000263	0.00623	CcSEcCtD
Tenoxicam—Malnutrition—Capecitabine—esophageal cancer	0.000263	0.00623	CcSEcCtD
Tenoxicam—Dyspnoea—Cisplatin—esophageal cancer	0.000259	0.00615	CcSEcCtD
Tenoxicam—Photosensitivity reaction—Methotrexate—esophageal cancer	0.000256	0.00607	CcSEcCtD
Tenoxicam—Decreased appetite—Cisplatin—esophageal cancer	0.000253	0.00599	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000251	0.00595	CcSEcCtD
Tenoxicam—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.000248	0.00588	CcSEcCtD
Tenoxicam—Stomatitis—Methotrexate—esophageal cancer	0.000244	0.00578	CcSEcCtD
Tenoxicam—Anaemia—Capecitabine—esophageal cancer	0.000243	0.00576	CcSEcCtD
Tenoxicam—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000237	0.00561	CcSEcCtD
Tenoxicam—Vertigo—Capecitabine—esophageal cancer	0.000236	0.0056	CcSEcCtD
Tenoxicam—Leukopenia—Capecitabine—esophageal cancer	0.000235	0.00557	CcSEcCtD
Tenoxicam—Agranulocytosis—Methotrexate—esophageal cancer	0.000234	0.00554	CcSEcCtD
Tenoxicam—Palpitations—Capecitabine—esophageal cancer	0.000232	0.0055	CcSEcCtD
Tenoxicam—Hepatitis—Methotrexate—esophageal cancer	0.000225	0.00533	CcSEcCtD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000222	0.00527	CcSEcCtD
Tenoxicam—Urinary tract disorder—Methotrexate—esophageal cancer	0.000222	0.00526	CcSEcCtD
Tenoxicam—Urethral disorder—Methotrexate—esophageal cancer	0.00022	0.00522	CcSEcCtD
Tenoxicam—Dry mouth—Capecitabine—esophageal cancer	0.000219	0.00519	CcSEcCtD
Tenoxicam—Visual impairment—Methotrexate—esophageal cancer	0.000217	0.00513	CcSEcCtD
Tenoxicam—Oedema—Capecitabine—esophageal cancer	0.000214	0.00508	CcSEcCtD
Tenoxicam—Hypersensitivity—Cisplatin—esophageal cancer	0.000214	0.00508	CcSEcCtD
Tenoxicam—Erythema multiforme—Methotrexate—esophageal cancer	0.000213	0.00504	CcSEcCtD
Tenoxicam—Nervous system disorder—Capecitabine—esophageal cancer	0.00021	0.00498	CcSEcCtD
Tenoxicam—Eye disorder—Methotrexate—esophageal cancer	0.00021	0.00498	CcSEcCtD
Tenoxicam—Thrombocytopenia—Capecitabine—esophageal cancer	0.00021	0.00498	CcSEcCtD
Tenoxicam—Asthenia—Cisplatin—esophageal cancer	0.000209	0.00495	CcSEcCtD
Tenoxicam—Cardiac disorder—Methotrexate—esophageal cancer	0.000209	0.00494	CcSEcCtD
Tenoxicam—Skin disorder—Capecitabine—esophageal cancer	0.000208	0.00494	CcSEcCtD
Tenoxicam—Anorexia—Capecitabine—esophageal cancer	0.000204	0.00484	CcSEcCtD
Tenoxicam—Angiopathy—Methotrexate—esophageal cancer	0.000204	0.00483	CcSEcCtD
Tenoxicam—Immune system disorder—Methotrexate—esophageal cancer	0.000203	0.00481	CcSEcCtD
Tenoxicam—Diarrhoea—Cisplatin—esophageal cancer	0.000199	0.00472	CcSEcCtD
Tenoxicam—Mental disorder—Methotrexate—esophageal cancer	0.000197	0.00467	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—GSTO1—esophageal cancer	0.000197	0.00416	CbGpPWpGaD
Tenoxicam—Malnutrition—Methotrexate—esophageal cancer	0.000196	0.00464	CcSEcCtD
Tenoxicam—Erythema—Methotrexate—esophageal cancer	0.000196	0.00464	CcSEcCtD
Tenoxicam—PTGS2—Selenium Micronutrient Network—PTGS1—esophageal cancer	0.000194	0.0041	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.000194	0.0041	CbGpPWpGaD
Tenoxicam—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.000193	0.00407	CbGpPWpGaD
Tenoxicam—Dyspnoea—Capecitabine—esophageal cancer	0.000191	0.00453	CcSEcCtD
Tenoxicam—Dyspepsia—Capecitabine—esophageal cancer	0.000189	0.00447	CcSEcCtD
Tenoxicam—PTGS2—Spinal Cord Injury—LGALS3—esophageal cancer	0.000187	0.00394	CbGpPWpGaD
Tenoxicam—Decreased appetite—Capecitabine—esophageal cancer	0.000186	0.00442	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000185	0.00439	CcSEcCtD
Tenoxicam—Vomiting—Cisplatin—esophageal cancer	0.000185	0.00438	CcSEcCtD
Tenoxicam—Fatigue—Capecitabine—esophageal cancer	0.000185	0.00438	CcSEcCtD
Tenoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.000184	0.00389	CbGpPWpGaD
Tenoxicam—Rash—Cisplatin—esophageal cancer	0.000183	0.00435	CcSEcCtD
Tenoxicam—Constipation—Capecitabine—esophageal cancer	0.000183	0.00435	CcSEcCtD
Tenoxicam—Dermatitis—Cisplatin—esophageal cancer	0.000183	0.00434	CcSEcCtD
Tenoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.000182	0.00384	CbGpPWpGaD
Tenoxicam—Anaemia—Methotrexate—esophageal cancer	0.000181	0.00428	CcSEcCtD
Tenoxicam—Vertigo—Methotrexate—esophageal cancer	0.000176	0.00417	CcSEcCtD
Tenoxicam—Leukopenia—Methotrexate—esophageal cancer	0.000175	0.00415	CcSEcCtD
Tenoxicam—Nausea—Cisplatin—esophageal cancer	0.000173	0.0041	CcSEcCtD
Tenoxicam—CYP2C9—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.000172	0.00363	CbGpPWpGaD
Tenoxicam—Urticaria—Capecitabine—esophageal cancer	0.00017	0.00404	CcSEcCtD
Tenoxicam—PTGS1—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000167	0.00352	CbGpPWpGaD
Tenoxicam—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000165	0.00392	CcSEcCtD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	0.000165	0.00349	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CXCL2—esophageal cancer	0.000162	0.00342	CbGpPWpGaD
Tenoxicam—PTGS1—Biological oxidations—ALDH2—esophageal cancer	0.00016	0.00339	CbGpPWpGaD
Tenoxicam—Anaphylactic shock—Methotrexate—esophageal cancer	0.00016	0.00378	CcSEcCtD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000159	0.00335	CbGpPWpGaD
Tenoxicam—Hypersensitivity—Capecitabine—esophageal cancer	0.000158	0.00374	CcSEcCtD
Tenoxicam—Nervous system disorder—Methotrexate—esophageal cancer	0.000157	0.00371	CcSEcCtD
Tenoxicam—Thrombocytopenia—Methotrexate—esophageal cancer	0.000156	0.0037	CcSEcCtD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	0.000155	0.00328	CbGpPWpGaD
Tenoxicam—Skin disorder—Methotrexate—esophageal cancer	0.000155	0.00368	CcSEcCtD
Tenoxicam—Asthenia—Capecitabine—esophageal cancer	0.000154	0.00365	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—GSTT1—esophageal cancer	0.000153	0.00322	CbGpPWpGaD
Tenoxicam—Anorexia—Methotrexate—esophageal cancer	0.000152	0.00361	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.000152	0.00321	CbGpPWpGaD
Tenoxicam—Pruritus—Capecitabine—esophageal cancer	0.000152	0.0036	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—CYP2A6—esophageal cancer	0.000151	0.00319	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000151	0.00318	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—ANXA1—esophageal cancer	0.00015	0.00318	CbGpPWpGaD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000149	0.00315	CbGpPWpGaD
Tenoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000148	0.00313	CbGpPWpGaD
Tenoxicam—PTGS1—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000147	0.00311	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	0.000147	0.00311	CbGpPWpGaD
Tenoxicam—Diarrhoea—Capecitabine—esophageal cancer	0.000147	0.00348	CcSEcCtD
Tenoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000146	0.00309	CbGpPWpGaD
Tenoxicam—Dyspnoea—Methotrexate—esophageal cancer	0.000142	0.00337	CcSEcCtD
Tenoxicam—Dizziness—Capecitabine—esophageal cancer	0.000142	0.00336	CcSEcCtD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.000142	0.00299	CbGpPWpGaD
Tenoxicam—Dyspepsia—Methotrexate—esophageal cancer	0.000141	0.00333	CcSEcCtD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—AQP3—esophageal cancer	0.00014	0.00296	CbGpPWpGaD
Tenoxicam—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00014	0.00295	CbGpPWpGaD
Tenoxicam—Decreased appetite—Methotrexate—esophageal cancer	0.000139	0.00329	CcSEcCtD
Tenoxicam—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000138	0.00327	CcSEcCtD
Tenoxicam—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.000138	0.00291	CbGpPWpGaD
Tenoxicam—Fatigue—Methotrexate—esophageal cancer	0.000138	0.00326	CcSEcCtD
Tenoxicam—CYP2C9—Biological oxidations—ADH7—esophageal cancer	0.000137	0.00288	CbGpPWpGaD
Tenoxicam—Vomiting—Capecitabine—esophageal cancer	0.000136	0.00323	CcSEcCtD
Tenoxicam—Rash—Capecitabine—esophageal cancer	0.000135	0.0032	CcSEcCtD
Tenoxicam—Dermatitis—Capecitabine—esophageal cancer	0.000135	0.0032	CcSEcCtD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ATP4A—esophageal cancer	0.000135	0.00284	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	0.000135	0.00284	CbGpPWpGaD
Tenoxicam—Headache—Capecitabine—esophageal cancer	0.000134	0.00318	CcSEcCtD
Tenoxicam—PTGS2—Selenium Micronutrient Network—SOD2—esophageal cancer	0.000132	0.0028	CbGpPWpGaD
Tenoxicam—Nausea—Capecitabine—esophageal cancer	0.000127	0.00302	CcSEcCtD
Tenoxicam—Urticaria—Methotrexate—esophageal cancer	0.000127	0.00301	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—CYP1B1—esophageal cancer	0.000122	0.00257	CbGpPWpGaD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00012	0.00254	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—ADH1B—esophageal cancer	0.00012	0.00253	CbGpPWpGaD
Tenoxicam—Hypersensitivity—Methotrexate—esophageal cancer	0.000118	0.00279	CcSEcCtD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000117	0.00248	CbGpPWpGaD
Tenoxicam—Asthenia—Methotrexate—esophageal cancer	0.000115	0.00271	CcSEcCtD
Tenoxicam—PTGS1—Biological oxidations—CYP19A1—esophageal cancer	0.000114	0.00241	CbGpPWpGaD
Tenoxicam—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.000113	0.00239	CbGpPWpGaD
Tenoxicam—Pruritus—Methotrexate—esophageal cancer	0.000113	0.00268	CcSEcCtD
Tenoxicam—CYP2C9—Biological oxidations—CYP26A1—esophageal cancer	0.000111	0.00235	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00011	0.00232	CbGpPWpGaD
Tenoxicam—Diarrhoea—Methotrexate—esophageal cancer	0.000109	0.00259	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.000109	0.00231	CbGpPWpGaD
Tenoxicam—Dizziness—Methotrexate—esophageal cancer	0.000106	0.0025	CcSEcCtD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.000104	0.00219	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.000103	0.00218	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.000102	0.00216	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.000102	0.00215	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ABCC2—esophageal cancer	0.000102	0.00215	CbGpPWpGaD
Tenoxicam—Vomiting—Methotrexate—esophageal cancer	0.000102	0.00241	CcSEcCtD
Tenoxicam—Rash—Methotrexate—esophageal cancer	0.000101	0.00239	CcSEcCtD
Tenoxicam—Dermatitis—Methotrexate—esophageal cancer	0.000101	0.00238	CcSEcCtD
Tenoxicam—Headache—Methotrexate—esophageal cancer	0.0001	0.00237	CcSEcCtD
Tenoxicam—Nausea—Methotrexate—esophageal cancer	9.48e-05	0.00225	CcSEcCtD
Tenoxicam—PTGS2—C-MYB transcription factor network—CREBBP—esophageal cancer	9.42e-05	0.00199	CbGpPWpGaD
Tenoxicam—PTGS1—Selenium Micronutrient Network—PTGS2—esophageal cancer	9.37e-05	0.00198	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	9.36e-05	0.00198	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	9.31e-05	0.00197	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—GNG7—esophageal cancer	9.25e-05	0.00195	CbGpPWpGaD
Tenoxicam—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—esophageal cancer	9.25e-05	0.00195	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	9.05e-05	0.00191	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	8.9e-05	0.00188	CbGpPWpGaD
Tenoxicam—PTGS2—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	8.86e-05	0.00187	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	8.43e-05	0.00178	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TLR4—esophageal cancer	8.41e-05	0.00178	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CDKN2A—esophageal cancer	8.25e-05	0.00174	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—BCL2—esophageal cancer	8.12e-05	0.00172	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	8.02e-05	0.00169	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—NOS2—esophageal cancer	8e-05	0.00169	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	7.93e-05	0.00167	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	7.92e-05	0.00167	CbGpPWpGaD
Tenoxicam—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	7.74e-05	0.00163	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	7.55e-05	0.00159	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	7.52e-05	0.00159	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	7.31e-05	0.00154	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	7.31e-05	0.00154	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—RB1—esophageal cancer	7.15e-05	0.00151	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CCND1—esophageal cancer	6.97e-05	0.00147	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	6.91e-05	0.00146	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	6.91e-05	0.00146	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—CDKN1A—esophageal cancer	6.75e-05	0.00142	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—EP300—esophageal cancer	6.42e-05	0.00136	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	6.39e-05	0.00135	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	6.3e-05	0.00133	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	6.29e-05	0.00133	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	6.16e-05	0.0013	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SLC52A3—esophageal cancer	6.14e-05	0.0013	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—BLVRB—esophageal cancer	6.14e-05	0.0013	CbGpPWpGaD
Tenoxicam—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	6.01e-05	0.00127	CbGpPWpGaD
Tenoxicam—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	5.93e-05	0.00125	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SLC52A3—esophageal cancer	5.82e-05	0.00123	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.64e-05	0.00119	CbGpPWpGaD
Tenoxicam—PTGS2—C-MYB transcription factor network—MYC—esophageal cancer	5.59e-05	0.00118	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—KMT2D—esophageal cancer	5.55e-05	0.00117	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.49e-05	0.00116	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.41e-05	0.00114	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—CCND1—esophageal cancer	5.31e-05	0.00112	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CA1—esophageal cancer	5.22e-05	0.0011	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—SLC10A2—esophageal cancer	5.22e-05	0.0011	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	4.91e-05	0.00104	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	4.88e-05	0.00103	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SLC52A3—esophageal cancer	4.88e-05	0.00103	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—BLVRB—esophageal cancer	4.88e-05	0.00103	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CA2—esophageal cancer	4.78e-05	0.00101	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	4.67e-05	0.000986	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PLCE1—esophageal cancer	4.44e-05	0.000938	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ADH7—esophageal cancer	4.44e-05	0.000938	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	4.39e-05	0.000927	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	4.36e-05	0.000921	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FKBP1A—esophageal cancer	4.31e-05	0.00091	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—MYC—esophageal cancer	4.26e-05	0.0009	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	4.21e-05	0.000889	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—DOCK2—esophageal cancer	4.21e-05	0.000889	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—WIF1—esophageal cancer	4.21e-05	0.000889	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—EGFR—esophageal cancer	4.17e-05	0.00088	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	4.16e-05	0.00088	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—SLC10A2—esophageal cancer	4.15e-05	0.000876	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CA1—esophageal cancer	4.15e-05	0.000876	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	4.09e-05	0.000864	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ADH1B—esophageal cancer	3.89e-05	0.000822	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CSNK1A1—esophageal cancer	3.88e-05	0.00082	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CA2—esophageal cancer	3.79e-05	0.000801	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—TYMP—esophageal cancer	3.72e-05	0.000786	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.71e-05	0.000783	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	3.63e-05	0.000767	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP26A1—esophageal cancer	3.62e-05	0.000765	CbGpPWpGaD
Tenoxicam—SLC22A8—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.62e-05	0.000764	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	3.61e-05	0.000763	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ALOX15—esophageal cancer	3.53e-05	0.000745	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PLCE1—esophageal cancer	3.53e-05	0.000745	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ADH7—esophageal cancer	3.53e-05	0.000745	CbGpPWpGaD
Tenoxicam—PTGS2—Spinal Cord Injury—TP53—esophageal cancer	3.5e-05	0.000739	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	3.5e-05	0.000738	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.48e-05	0.000736	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTO1—esophageal cancer	3.37e-05	0.000711	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—TPI1—esophageal cancer	3.37e-05	0.000711	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	3.33e-05	0.000703	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ELMO1—esophageal cancer	3.26e-05	0.000689	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC52A3—esophageal cancer	3.23e-05	0.000682	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—BLVRB—esophageal cancer	3.23e-05	0.000682	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ALDOB—esophageal cancer	3.23e-05	0.000681	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—GSTO1—esophageal cancer	3.19e-05	0.000674	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TPI1—esophageal cancer	3.19e-05	0.000674	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GAPDH—esophageal cancer	3.11e-05	0.000656	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ADH1B—esophageal cancer	3.09e-05	0.000653	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CRABP1—esophageal cancer	3.08e-05	0.00065	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ALDOB—esophageal cancer	3.06e-05	0.000646	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—TYMP—esophageal cancer	2.95e-05	0.000624	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HIST1H2BM—esophageal cancer	2.94e-05	0.000622	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—GAPDH—esophageal cancer	2.94e-05	0.000622	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GNG7—esophageal cancer	2.93e-05	0.000618	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.9e-05	0.000612	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	2.89e-05	0.00061	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP26A1—esophageal cancer	2.87e-05	0.000607	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.84e-05	0.000599	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ALOX15—esophageal cancer	2.8e-05	0.000591	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CA1—esophageal cancer	2.75e-05	0.00058	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—SLC10A2—esophageal cancer	2.75e-05	0.00058	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ALDH2—esophageal cancer	2.74e-05	0.000579	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTO1—esophageal cancer	2.67e-05	0.000564	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—TPI1—esophageal cancer	2.67e-05	0.000564	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—GSTT1—esophageal cancer	2.61e-05	0.000551	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—XIAP—esophageal cancer	2.6e-05	0.000549	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP2A6—esophageal cancer	2.58e-05	0.000545	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.57e-05	0.000543	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ALDOB—esophageal cancer	2.56e-05	0.000541	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CA2—esophageal cancer	2.51e-05	0.00053	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GAPDH—esophageal cancer	2.47e-05	0.000521	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	2.46e-05	0.00052	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	2.45e-05	0.000518	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ENO1—esophageal cancer	2.45e-05	0.000516	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CRABP1—esophageal cancer	2.44e-05	0.000516	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—B2M—esophageal cancer	2.42e-05	0.000511	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PSME1—esophageal cancer	2.41e-05	0.000509	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PSME2—esophageal cancer	2.41e-05	0.000509	CbGpPWpGaD
Tenoxicam—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	2.38e-05	0.000503	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ADH7—esophageal cancer	2.33e-05	0.000493	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PLCE1—esophageal cancer	2.33e-05	0.000493	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GNG7—esophageal cancer	2.32e-05	0.000491	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ENO1—esophageal cancer	2.32e-05	0.00049	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	2.31e-05	0.000487	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PSME2—esophageal cancer	2.28e-05	0.000482	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PSME1—esophageal cancer	2.28e-05	0.000482	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CALR—esophageal cancer	2.19e-05	0.000463	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ALDH2—esophageal cancer	2.18e-05	0.00046	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—FBXW7—esophageal cancer	2.12e-05	0.000448	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.1e-05	0.000444	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP1B1—esophageal cancer	2.08e-05	0.000439	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—GSTT1—esophageal cancer	2.07e-05	0.000438	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP2A6—esophageal cancer	2.05e-05	0.000432	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.05e-05	0.000432	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	2.04e-05	0.000431	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—TYMP—esophageal cancer	1.96e-05	0.000413	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CYP19A1—esophageal cancer	1.95e-05	0.000413	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PTGS1—esophageal cancer	1.94e-05	0.00041	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ENO1—esophageal cancer	1.94e-05	0.00041	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PSME2—esophageal cancer	1.91e-05	0.000404	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PSME1—esophageal cancer	1.91e-05	0.000404	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP26A1—esophageal cancer	1.9e-05	0.000402	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ALOX15—esophageal cancer	1.85e-05	0.000392	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—HMOX1—esophageal cancer	1.78e-05	0.000377	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—TPI1—esophageal cancer	1.77e-05	0.000374	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTO1—esophageal cancer	1.77e-05	0.000374	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.75e-05	0.00037	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—TGFBR2—esophageal cancer	1.71e-05	0.000362	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—ABCB1—esophageal cancer	1.71e-05	0.000362	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ALDOB—esophageal cancer	1.7e-05	0.000358	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP1B1—esophageal cancer	1.65e-05	0.000349	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GAPDH—esophageal cancer	1.63e-05	0.000345	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—SMAD4—esophageal cancer	1.62e-05	0.000343	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CRABP1—esophageal cancer	1.62e-05	0.000342	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CYP19A1—esophageal cancer	1.55e-05	0.000328	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GNG7—esophageal cancer	1.54e-05	0.000325	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.44e-05	0.000305	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—HMOX1—esophageal cancer	1.42e-05	0.000299	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.39e-05	0.000293	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.37e-05	0.00029	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—ABCB1—esophageal cancer	1.36e-05	0.000287	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.36e-05	0.000286	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.35e-05	0.000285	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—HIF1A—esophageal cancer	1.33e-05	0.00028	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.29e-05	0.000273	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ENO1—esophageal cancer	1.29e-05	0.000271	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.29e-05	0.000271	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PSME2—esophageal cancer	1.27e-05	0.000268	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PSME1—esophageal cancer	1.27e-05	0.000268	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NOS2—esophageal cancer	1.21e-05	0.000255	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NOTCH1—esophageal cancer	1.2e-05	0.000253	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—CREBBP—esophageal cancer	1.14e-05	0.000242	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.11e-05	0.000234	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.09e-05	0.000231	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CREBBP—esophageal cancer	1.08e-05	0.000229	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.03e-05	0.000217	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.03e-05	0.000217	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—NOS3—esophageal cancer	1.02e-05	0.000216	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—NOS3—esophageal cancer	9.71e-06	0.000205	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—HMOX1—esophageal cancer	9.38e-06	0.000198	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PTGS2—esophageal cancer	9.37e-06	0.000198	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.2e-06	0.000194	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—CREBBP—esophageal cancer	9.08e-06	0.000192	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—ERBB2—esophageal cancer	9.08e-06	0.000192	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—ABCB1—esophageal cancer	9e-06	0.00019	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—NOS3—esophageal cancer	8.13e-06	0.000172	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—EP300—esophageal cancer	7.79e-06	0.000165	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—CDKN1A—esophageal cancer	7.76e-06	0.000164	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—EP300—esophageal cancer	7.39e-06	0.000156	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.81e-06	0.000144	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—MYC—esophageal cancer	6.44e-06	0.000136	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—EGFR—esophageal cancer	6.3e-06	0.000133	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—EP300—esophageal cancer	6.19e-06	0.000131	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—CREBBP—esophageal cancer	6.02e-06	0.000127	CbGpPWpGaD
Tenoxicam—PTGS1—Metabolism—PIK3CA—esophageal cancer	5.76e-06	0.000122	CbGpPWpGaD
Tenoxicam—PTGS2—Disease—PIK3CA—esophageal cancer	5.46e-06	0.000115	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—NOS3—esophageal cancer	5.39e-06	0.000114	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PTGS2—esophageal cancer	4.93e-06	0.000104	CbGpPWpGaD
Tenoxicam—PTGS2—Metabolism—PIK3CA—esophageal cancer	4.58e-06	9.67e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—EP300—esophageal cancer	4.1e-06	8.65e-05	CbGpPWpGaD
Tenoxicam—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.03e-06	6.4e-05	CbGpPWpGaD
